Retinol-binding protein 4 (RBP4), an adipokine responsible for obesity-induced insulin resistance, has been identified as one of the reliable biomarkers for the early diagnosis of T2DM [4]. Here, RBP4 is linked to obesity due to melanocortin 4 receptor deficiency.